华泰金融(HK)9月15日发布公告。On September 11, stapokibart was approved by the NMPA for moderate-to-severe AD in adults, becoming the first domestic anti-IL-4RαmAb approved (second globally). We are bullish about ...
备注:排名不分先后 肺癌 摘要号:1255MO A Phase II Safety and Efficacy Study of PM8002/BNT-327 in Combination with Chemotherapy in Patients with EGFR-mutated Non-Small Cell Lung Cancer (NSCLC) ...